Pyrrolo[2, 3-D]pyrimidines and use thereof as tyrosine kinase inhibitors

Details for Australian Patent Application No. 2009211338 (hide)

Owner Novartis AG

Inventors Gerspacher, Marc; Pissot Soldermann, Carole; Gaul, Christoph; Holzer, Philipp

Agent Davies Collison Cave

Pub. Number AU-B-2009211338

PCT Pub. Number WO2009/098236

Priority 08151137.0 06.02.08 EP

Filing date 4 February 2009

Wipo publication date 13 August 2009

Acceptance publication date 15 December 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/098236 Priority application(s): WO2009/098236

15 December 2011 Application Accepted

  Published as AU-B-2009211338

12 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009211339-A milk analysis microfluidic apparatus for detecting mastitis in a milk sample

2009211333-Macrolides for treating diseases mediated through PDE inhibition